Prospective Registration and Assessment of Serious Adverse Events Within the AFNET
CompletedOBSERVATIONAL
Enrollment
13,000
Participants
Timeline
Start Date
February 29, 2004
Primary Completion Date
October 31, 2012
Study Completion Date
December 31, 2012
Conditions
Atrial FibrillationAssessment of Serious Advers EventsThromboembolic and Bleeding ComplicationsComplications of Antiarrhythmic Drugs or Invasive ProceduresAssessment by a Critical Event Committee
Trial Locations (1)
14770
Staedt. Klinikum, Department of Cardiology, Brandenburg
All Listed Sponsors
lead
Atrial Fibrillation Network
OTHER
NCT01678456 - Prospective Registration and Assessment of Serious Adverse Events Within the AFNET | Biotech Hunter | Biotech Hunter